T1	Participants 272 306	individuals with amalgam fillings.
T2	Participants 578 618	dyspeptic patients with amalgam fillings
T3	Participants 729 873	Four hundred and seventy-five patients who presented with dyspeptic complaints and underwent upper gastrointestinal endoscopy and gastric biopsy